M. Cogne
16 Papers
56 Citations
M. Cogne is an academic researcher. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 7, co-authored 12 publications.
Chat about Author
Papers
Genetic analysis in young patients with sporadic pituitary macroadenomas: besides AIP don't forget MEN1 genetic analysis
Thomas Cuny,Morgane Pertuit,M Sahnoun-Fathallah,Adrian Daly,Gianluca Occhi,Marie Françoise Odou,Antoine Tabarin,Marie Laure Nunes,Brigitte Delemer,Vincent Rohmer,Rachel Desailloud,Véronique Kerlan,Olivier Chabre,Jean-Louis Sadoul,M. Cogne,Philippe Caron,Christine Cortet-Rudelli,Anne Lienhardt,Isabelle Raingeard,Anne-Marie Guedj,Thierry Brue,Albert Beckers,Georges Weryha,Alain Enjalbert,Anne Barlier +24 more
TL;DR: Mutations in MEN1 can be of significance in young patients with sporadic isolated pituitary macroadenomas, particularly PRL, and together with AIP, are suggested to suggest genetic analysis of MEN1 in such a population.
French consensus on the management of acromegaly.
Philippe Chanson,Jérôme Bertherat,Albert Beckers,Hélène Bihan,Thierry Brue,P. Caron,Olivier Chabre,M. Cogne,Christine Cortet-Rudelli,B. Delemer,H. Dufour,R. C. Gaillard,M. Gueydan,I. Morange,Jean-Claude Souberbielle,A. Tabarin +15 more
TL;DR: On behalf of the Club français de l’hypophyse (French Pituitary Club) and of the Société française d’endocrinologie (French Endocrinology Society)
34
Variable growth hormone profiles following withdrawal of long-term 30mg slow-release lanreotide treatment in acromegalic patients: clinical implications.
TL;DR: The degree of responsiveness to Lanreotide and the duration of somatotroph suppression following lanreotide withdrawal are variable in acromegalic patients controlled during long-term 30mg SR lanreocide treatment.
A recurrent familial partial lipodystrophy due to a monoallelic or biallelic LMNA founder variant highlights the multifaceted cardiac manifestations of metabolic laminopathies.
Guillaume Treiber,Ania Flaus Furmaniuk,Alice Guilleux,Samir Medjane,Oriane Bonfanti,Stéphane Schneebeli,Céline Bernard,Nathalie Le-Moullec,Faouzi Bakiri,Maryse Pholsena,Olivier Rollot,Camille Vatier,Eric Jarlet,Isabelle Jéru,Olivier Lascols,Françoise Darcel,Bhoopendrasing Domun,Adrien Venault,Sophie Venault,Marie-Line Jacquemont,Bérénice Doray,Jean-Christophe Maiza,M. Cogne,Corinne Vigouroux,Estelle Nobecourt,Estelle Nobecourt +25 more
TL;DR: In this article, the level of expression of the LMNA 'Reunionese' variant determines the severity of both lipoatrophy and metabolic complications, leading to death in four cases.
16
Androgenic granulosa cell tumor of the ovary: in vivo hormonal studies
TL;DR: A 20-year-old woman complaining of secondary amenorrhea with high plasma testosterone with high Plasma testosterone and a right ovarian tumor was studied and the patient had resumption of normal menses.
16